A new guideline on systemic lupus erythematosus (SLE) was released by the British Society for Rheumatology (BSR). The society's Standards, Audit and Guidelines Working Group published the guideline ...
The European Alliance of Associations for Rheumatology (EULAR) has updated its recommendations for the management of systemic lupus erythematosus (SLE) based on emerging new evidence. For the 2023 ...
SLE is a heterogeneous disease, which can cause many different manifestations and symptoms, and traditionally did not have many treatment options. However, the picture is changing, and clinical ...
The new EULAR recommendations were developed by a multidisciplinary task force of patient research partners, nurses, and health care professionals from rheumatology as well as experts in physiotherapy ...
Allocation of therapy for systemic lupus erythematosus (SLE) remains complex, as most drugs used to treat this disease are used off-label—a situation compounded by the emergence of new therapeutics.
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multisystem involvement. Systemic sclerosis (SSc) or scleroderma is another rheumatic autoimmune disease that ...
SLE is a heterogeneous disease, which can cause many different manifestations and symptoms, and traditionally did not have many treatment options. However, the picture is changing, and clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results